Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Golab, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 33 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zagozdzon, R; Golab, J
      Immunomodulation by anticancer chemotherapy: More is not always better (review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    2. Golab, J; Zagozdzon, R; Kaminski, R; Kozar, K; Gryska, K; Izycki, D; Mackiewicz, A; Stoklosa, T; Giermasz, A; Lasek, W; Jakobisiak, M
      Potentiated antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo

      LEUKEMIA
    3. Maiti, A; Sierka, M; Andzelm, J; Golab, J; Sauer, J
      Combined quantum mechanics: Interatomic potential function investigation of rac-meso configurational stability and rotational transition in zirconocene-based Ziegler-Natta

      JOURNAL OF PHYSICAL CHEMISTRY A
    4. Golab, J
      Interleukin 18 - Interferon gamma inducing factor - A novel player in tumour immunotherapy?

      CYTOKINE
    5. Golab, J; Zagozdzon, R; Kozar, K; Kaminski, R; Giermasz, A; Stoklosa, T; Lasek, W; Jakobisiak, M
      Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo

      ONCOLOGY REPORTS
    6. Lasek, W; Mackiewicz, A; Czajka, A; Switaj, T; Golab, J; Wiznerowicz, M; Korczak-Kowalska, G; Bakowiec-Iskra, EZ; Gryska, K; Izycki, D; Jakobisiak, M
      Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice

      CANCER GENE THERAPY
    7. Golab, J; Stoklosa, T; Czajka, A; Dabrowska, A; Jakobisiak, M; Zagozdzon, R; Wojcik, C; Marczak, M; Wilk, S
      Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice

      ANTICANCER RESEARCH
    8. Dabrowska, A; Giermasz, A; Marczak, M; Golab, J; Jakobisiak, M
      Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice

      ANTICANCER RESEARCH
    9. Golab, J; Zagozdzon, R; Stoklosal, T; Kaminski, R; Kozar, K; Jakobisiak, M
      Direct stimulation of macrophages by IL-12 and IL-18 - a bridge too far?

      IMMUNOLOGY LETTERS
    10. Golab, J; Kozar, K; Kaminski, R; Czajka, A; Marczak, M; Switaj, T; Giermasz, A; Stoklosa, T; Lasek, W; Zagozdzon, R; Mucha, K; Jakobisiak, M
      Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice

      LIFE SCIENCES
    11. Golab, J; Wilczynski, G; Zagozdzon, R; Stoklosa, T; Dabrowska, A; Rybczynska, J; Wasik, M; Machaj, E; Oldak, T; Kozar, K; Kaminski, R; Giermasz, A; Czajka, A; Lasek, W; Feleszko, W; Jakobisiak, M
      Potentiation of the anti-tumour effects of Photofrin (R)-based photodynamic therapy by localized treatment with G-CSF

      BRITISH JOURNAL OF CANCER
    12. Lasek, W; Golab, J; Maslinski, W; Switaj, T; Balkowiec, EZ; Stoklosa, T; Giermasz, A; Malejczyk, M; Jakobisiak, M
      Subtherapeutic doses of interleukin-15 augment the anti-tumor effect of interleukin-12 in a B16F10 melanoma model in mice

      EUROPEAN CYTOKINE NETWORK
    13. Zagozdzon, R; Golab, J; Mucha, K; Foroncewicz, B; Jakobisiak, M
      Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    14. Golab, J; Zagozdzon, R
      Antitumor effects of interleukin-12 in pre-clinical and early clinical studies (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    15. Zagozdzon, R; Giermasz, A; Golab, J; Stoklosa, T; Jalili, A; Jakobisiak, M
      The potentiated antileukemic effects of doxorubicin and interleukin-12 combination are not dependent on nitric oxide production

      CANCER LETTERS
    16. Stoklosa, T; Wojcik, C; Golab, J; Giermasz, A; Wilk, S
      Inhibition of proteasome, apoptosis and sensitization to tumour necrosis factor alpha: do they always go together?

      BRITISH JOURNAL OF CANCER
    17. Wojcik, C; Mlynarczuk, I; Hoser, G; Kawiak, J; Stoklosa, T; Golab, J; Wilk, S
      A combination of retinoic acid and proteasome inhibitors for the treatmentof leukemias is potentially dangerous

      BLOOD
    18. Dabrowska, A; Golab, J; Giermasz, A; Marczak, M; Jakobisiak, M
      Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    19. GOLAB J; STOKLOSA T; ZAGOZDZON R; KACA A; KULCHITSKA LA; FELESZKO W; KAWIAK J; HOSER G; GLOWACKA E; DABROWSKA A; GIERMASZ A; LASEK W; JAKOBISIAK M
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR POTENTIATES ANTITUMOR-ACTIVITY OF INTERLEUKIN-12 IN MELANOMA MODEL IN MICE

      Tumor biology
    20. FELESZKO W; ZAGOZDZON R; GOLAB J; JAKOBISIAK M
      POTENTIATED ANTITUMOR EFFECTS OF CISPLATIN AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE

      European journal of cancer
    21. GOLAB J; STOKLOSA T; ZAGOZDZON R; KACA A; GIERMASZ A; POJDA Z; MACHAJ E; DABROWSKA A; FELESZKO W; LASEK W; IWANOSIECKA A; JAKOBISIAK M
      G-CSF PREVENTS THE SUPPRESSION OF BONE-MARROW HEMATOPOIESIS INDUCED BY IL-12 AND AUGMENTS ITS ANTITUMOR-ACTIVITY IN A MELANOMA MODEL IN MICE

      Annals of oncology
    22. PYRON C; PRADO J; GOLAB J
      TEST STRATEGY FOR THE POWERPC-750 MICROPROCESSOR

      IEEE design & test of computers
    23. GOLAB J; ZAGOZDZON R; STOKLOSA T; KACA A; DABROWSKA A; GIERMASZ A; FELESZKO W; JAKOBISIAK M
      GRANULOCYTE-COLONY-STIMULATING FACTOR DEMONSTRATES ANTITUMOR-ACTIVITYIN MELANOMA MODEL IN MICE

      Neoplasma
    24. ZAGOZDZON R; GOLAB J; STOKLOSA T; GIERMASZ A; NOWICKA D; FELESZKO W; LASEK W; JAKOBISIAK M
      EFFECTIVE CHEMOIMMUNOTHERAPY OF L1210 LEUKEMIA IN-VIVO USING INTERLEUKIN-12 COMBINED WITH DOXORUBICIN BUT NOT WITH CYCLOPHOSPHAMIDE, PACLITAXEL OR CISPLATIN

      International journal of cancer
    25. GOLAB J; ZAGOZDZON R; STOKLOSA T; LASEK W; JAKOBISIAK M; POJDA Z; MACHAJ E
      ERYTHROPOIETIN PREVENTS THE DEVELOPMENT OF INTERLEUKIN-12-INDUCED ANEMIA AND THROMBOCYTOPENIA BUT DOES NOT DECREASE ITS ANTITUMOR-ACTIVITY IN MICE

      Blood
    26. WOJCIK C; STOKLOSA T; GIERMASZ A; GOLAB J; ZAGOZDZON R; KAWIAK J; WILK S; KOMAR A; KACA A; MALEJCZYK J; JAKOBISIAK M
      APOPTOSIS INDUCED IN L1210 LEUKEMIA-CELLS BY AN INHIBITOR OF THE CHYMOTRYPSIN-LIKE ACTIVITY OF THE PROTEASOME

      Apoptosis
    27. LASEK W; FELESZKO W; GOLAB J; STOKLOSA T; MARCZAK M; DABROWSKA A; MALEJCZYK M; JAKOBISIAK M
      ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE

      European journal of cancer
    28. LASEK W; FELESZKO W; GOLAB J; STOKLOSA T; MARCZAK M; DABROWSKA A; MALEJCZYK M; JAKOBISIAK M
      ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE

      Cancer immunology and immunotherapy
    29. ZAGOZDZON R; STOKLOSA T; GOLAB J; GIERMASZ A; DABROWSKA A; LASEK W; JAKOBISIAK M
      AUGMENTED ANTITUMOR EFFECTS OF COMBINATION THERAPY WITH INTERLEUKIN-12, CISPLATIN, AND TUMOR-NECROSIS-FACTOR-ALPHA IN A MURINE MELANOMA MODEL

      Anticancer research
    30. LASEK W; GIERMASZ A; KUC K; WANKOWICZ A; FELESZKO W; GOLAB J; ZAGOZDZON R; STOKLOSA T; JAKOBISIAK M
      POTENTIATION OF THE ANTITUMOR EFFECT OF ACTINOMYCIN-D BY TUMOR-NECROSIS-FACTOR-ALPHA IN MICE - CORRELATION BETWEEN IN-VITRO AND IN-VIVO RESULTS

      International journal of cancer
    31. LASEK W; WANKOWICZ A; KUC K; FELESZKO W; GOLAB J; GIERMASZ A; WIKTORJEDRZEJCZAK W; JAKOBISIAK M
      POTENTIATION OF ANTITUMOR EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA BY MACROPHAGE-COLONY-STIMULATING FACTOR IN A MMB16 MELANOMA MODEL IN MICE

      Cancer immunology and immunotherapy
    32. FELESZKO W; LASEK W; GOLAB J; JAKOBISIAK M
      SYNERGISTIC ANTITUMOR-ACTIVITY OF TUMOR-NECROSIS-FACTOR-ALPHA AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE

      Neoplasma
    33. GEROSA G; GARY S; DIETZ C; PHAM D; HOOVER K; ALVAREZ J; SANCHEZ H; IPPOLITO P; NGO T; LITCH S; ENO J; GOLAB J; VANDERSCHAAF N; KAHLE J
      A 2.2-W, 80-MHZ SUPERSCALAR RISC MICROPROCESSOR

      IEEE journal of solid-state circuits


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 13:36:37